Emapalumab for Maladaptive Interferon-γ-Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First-Line Antituberculosis Therapy. - Almodallal Y; Whitehurst D; Way SS; Koo J; Kumar AR (Pediatric blood & cancer, 2025)